-0.89%
Today
Loading 1D prices…
Company profile
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Princeton, BC, United States
Fiscal year end
0930
CIK
2027329
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ATOSAtossa Therapeutics Inc. Common Stock | $25M | $0.00 | — | -$4.04 | +7.26% | Buy |
| TXMDTherapeuticsMD Inc. Common Stock | $25M | $3M | -18.83% | -$0.05 | +2.86% | Unrated |
| TVRDTvardi Therapeutics Inc. Common Stock | $24.9M | $0.00 | — | -$3.26 | +1.91% | Buy |
| ACTUActuate Therapeutics Inc. Common stock | $25.7M | $0.00 | — | -$1.06 | -6.96% | Buy |
| NNVCNanoViricides Inc. Common Stock | $26M | $0.00 | — | -$0.31 | -0.98% | Buy |